Skip to main content
Human Gene HSD3B7 (ENST00000297679.10) from GENCODE V49
  Description: hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7, transcript variant 1 (from RefSeq NM_025193.4)
Gencode Transcript: ENST00000297679.10
Gencode Gene: ENSG00000099377.15
Transcript (Including UTRs)
   Position: hg38 chr16:30,985,207-30,989,147 Size: 3,941 Total Exon Count: 7 Strand: +
Coding Region
   Position: hg38 chr16:30,985,659-30,988,183 Size: 2,525 Coding Exon Count: 6 

Page IndexSequence and LinksUniProtKB CommentsPrimersMalaCardsCTD
RNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein StructureOther SpeciesGO Annotations
mRNA DescriptionsPathwaysOther NamesGeneReviewsMethods
Data last updated at UCSC: 2025-09-17 13:57:07

-  Comments and Description Text from UniProtKB
  ID: 3BHS7_HUMAN
DESCRIPTION: RecName: Full=3 beta-hydroxysteroid dehydrogenase type 7; AltName: Full=3 beta-hydroxysteroid dehydrogenase type VII; Short=3-beta-HSD VII; AltName: Full=3-beta-hydroxy-Delta(5)-C27 steroid oxidoreductase; Short=C(27) 3-beta-HSD; EC=1.1.1.-; AltName: Full=Cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase; EC=1.1.1.181;
FUNCTION: The 3-beta-HSD enzymatic system plays a crucial role in the biosynthesis of all classes of hormonal steroids. HSD VII is active against four 7-alpha-hydroxylated sterols. Does not metabolize several different C(19/21) steroids as substrates. Involved in bile acid synthesis.
CATALYTIC ACTIVITY: 3-beta-hydroxy-Delta(5)-steroid + NAD(+) = 3- oxo-Delta(5)-steroid + NADH.
CATALYTIC ACTIVITY: Cholest-5-ene-3-beta,7-alpha-diol + NAD(+) = 7-alpha-hydroxycholest-4-en-3-one + NADH.
PATHWAY: Lipid metabolism; steroid biosynthesis.
SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Multi-pass membrane protein.
DISEASE: Defects in HSD3B7 are the cause of congenital bile acid synthesis defect type 1 (CBAS1) [MIM:607765]; also known as neonatal progressive intrahepatic cholestasis. CBAS1 is due to a primary defect in bile synthesis leading to progressive liver disease. Clinical features include neonatal jaundice, severe intrahepatic cholestasis and cirrhosis.
SIMILARITY: Belongs to the 3-beta-HSD family.

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  MalaCards Disease Associations
  MalaCards Gene Search: HSD3B7
Diseases sorted by gene-association score: bile acid synthesis defect, congenital, 1* (1650), congenital bile acid synthesis defect (46), cholestasis (21), liver disease (16), intrahepatic cholestasis (11)
* = Manually curated disease association

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene           more ... click here to view the complete list

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 50.63 RPKM in Liver
Total median expression: 445.22 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
 
Expression ratio colors:

GNF Expression Atlas 2 Data from U133A and GNF1H Chips

      
      
      
     
    
     
Ratios
      
      
      
     
    
     
Absolute
      
       
      
      
     
    
Ratios
      
       
      
      
     
    
Absolute
   
     
     
Ratios
   
     
     
Absolute

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -37.5097-0.387 Picture PostScript Text
3' UTR -384.60964-0.399 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR002225 - 3Beta_OHSteriod_DH/Estase
IPR016040 - NAD(P)-bd_dom

Pfam Domains:
PF01073 - 3-beta hydroxysteroid dehydrogenase/isomerase family

ModBase Predicted Comparative 3D Structure on Q9H2F3
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
Genome BrowserGenome BrowserNo orthologNo orthologNo orthologNo ortholog
Gene Details     
Gene Sorter     
MGIRGD    
Protein SequenceProtein Sequence    
AlignmentAlignment    

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0003854 3-beta-hydroxy-delta5-steroid dehydrogenase activity
GO:0005515 protein binding
GO:0016491 oxidoreductase activity
GO:0016616 oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
GO:0047016 cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity

Biological Process:
GO:0006694 steroid biosynthetic process
GO:0006699 bile acid biosynthetic process
GO:0035754 B cell chemotaxis
GO:0055114 oxidation-reduction process

Cellular Component:
GO:0005575 cellular_component
GO:0005783 endoplasmic reticulum
GO:0005789 endoplasmic reticulum membrane
GO:0005811 lipid particle
GO:0016020 membrane
GO:0016021 integral component of membrane


-  Descriptions from all associated GenBank mRNAs
  AK057436 - Homo sapiens cDNA FLJ32874 fis, clone TESTI2004000, highly similar to Rattus norvegicus cca2 mRNA.
BC004929 - Homo sapiens hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7, mRNA (cDNA clone MGC:10497 IMAGE:3626629), complete cds.
JD209396 - Sequence 190420 from Patent EP1572962.
AK290950 - Homo sapiens cDNA FLJ78573 complete cds.
AK292068 - Homo sapiens cDNA FLJ78326 complete cds.
AF277719 - Homo sapiens 3 beta-hydroxy-delta 5-C27-steroid oxidoreductase mRNA, complete cds.
KJ901075 - Synthetic construct Homo sapiens clone ccsbBroadEn_10469 HSD3B7 gene, encodes complete protein.
EU176407 - Synthetic construct Homo sapiens clone IMAGE:100006554; FLH263536.01X; RZPDo839H0867D hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 (HSD3B7) gene, encodes complete protein.
EU176408 - Synthetic construct Homo sapiens clone IMAGE:100006555; FLH263537.01X; RZPDo839F12255D hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 (HSD3B7) gene, encodes complete protein.
JD057966 - Sequence 38990 from Patent EP1572962.
JD226588 - Sequence 207612 from Patent EP1572962.
JD296058 - Sequence 277082 from Patent EP1572962.
JD454179 - Sequence 435203 from Patent EP1572962.
JD267375 - Sequence 248399 from Patent EP1572962.
JD084909 - Sequence 65933 from Patent EP1572962.
JD248808 - Sequence 229832 from Patent EP1572962.
JD110427 - Sequence 91451 from Patent EP1572962.
JD508636 - Sequence 489660 from Patent EP1572962.
JD337682 - Sequence 318706 from Patent EP1572962.
JD337683 - Sequence 318707 from Patent EP1572962.
JD463222 - Sequence 444246 from Patent EP1572962.
JD463223 - Sequence 444247 from Patent EP1572962.
JD413795 - Sequence 394819 from Patent EP1572962.
JD367547 - Sequence 348571 from Patent EP1572962.
JD367548 - Sequence 348572 from Patent EP1572962.
JD363173 - Sequence 344197 from Patent EP1572962.
JD151013 - Sequence 132037 from Patent EP1572962.
JD131721 - Sequence 112745 from Patent EP1572962.
JD070377 - Sequence 51401 from Patent EP1572962.
JD398580 - Sequence 379604 from Patent EP1572962.
JD150696 - Sequence 131720 from Patent EP1572962.
JD150697 - Sequence 131721 from Patent EP1572962.
JD071882 - Sequence 52906 from Patent EP1572962.
JD330776 - Sequence 311800 from Patent EP1572962.
JD441201 - Sequence 422225 from Patent EP1572962.
JD255843 - Sequence 236867 from Patent EP1572962.
JD217020 - Sequence 198044 from Patent EP1572962.
JD504491 - Sequence 485515 from Patent EP1572962.
JD362791 - Sequence 343815 from Patent EP1572962.
JD483764 - Sequence 464788 from Patent EP1572962.
JD369206 - Sequence 350230 from Patent EP1572962.
JD547428 - Sequence 528452 from Patent EP1572962.
JD497422 - Sequence 478446 from Patent EP1572962.
JD123748 - Sequence 104772 from Patent EP1572962.
JD421036 - Sequence 402060 from Patent EP1572962.
JD468823 - Sequence 449847 from Patent EP1572962.
JD462757 - Sequence 443781 from Patent EP1572962.
JD429372 - Sequence 410396 from Patent EP1572962.
JD197498 - Sequence 178522 from Patent EP1572962.

-  Biochemical and Signaling Pathways
  KEGG - Kyoto Encyclopedia of Genes and Genomes
hsa00120 - Primary bile acid biosynthesis
hsa01100 - Metabolic pathways

BioCyc Knowledge Library
PWY-6061 - bile acid biosynthesis, neutral pathway

Reactome (by CSHL, EBI, and GO)

Protein Q9H2F3 (Reactome details) participates in the following event(s):

R-HSA-192097 7alpha-hydroxycholesterol is oxidized and isomerized to 4-cholesten-7alpha-ol-3-one
R-HSA-193789 Cholest-5-ene-3beta,7alpha,24(S)-triol is oxidized and isomerized to 4-cholesten-7alpha,24(S)-diol-3-one
R-HSA-193816 Cholest-5-ene-3beta,7alpha,27-triol is oxidized and isomerized to 4-cholesten-7alpha,27-diol-3-one
R-HSA-193368 Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol
R-HSA-193775 Synthesis of bile acids and bile salts via 24-hydroxycholesterol
R-HSA-193807 Synthesis of bile acids and bile salts via 27-hydroxycholesterol
R-HSA-192105 Synthesis of bile acids and bile salts
R-HSA-194068 Bile acid and bile salt metabolism
R-HSA-8957322 Metabolism of steroids
R-HSA-556833 Metabolism of lipids
R-HSA-1430728 Metabolism

-  Other Names for This Gene
  Alternate Gene Symbols: 3BHS7_HUMAN, ENST00000297679.1, ENST00000297679.2, ENST00000297679.3, ENST00000297679.4, ENST00000297679.5, ENST00000297679.6, ENST00000297679.7, ENST00000297679.8, ENST00000297679.9, HSD3B7 , NM_025193, Q96M28, Q9BSN9, Q9H2F3, uc002eaf.1, uc002eaf.2, uc002eaf.3, uc002eaf.4
UCSC ID: ENST00000297679.10
RefSeq Accession: NM_025193.4
Protein: Q9H2F3 (aka 3BHS7_HUMAN or 3BH7_HUMAN)
CCDS: CCDS10698.1

-  GeneReviews for This Gene
  GeneReviews article(s) related to gene HSD3B7:
chol-liver-ov (Pediatric Genetic Cholestatic Liver Disease Overview)

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.